In addition to the demands for evidence-based regimens, today's orthopedic societies are faced with the challenge of treating the patients by means of cost-effective regimes. Recent randomized controlled trials (RCTs) have investigated the effect of lumbar spinal fusion in patients with chronic low back pain [5, 6, 13, 15, 16, 29, 30, 41] . Abstract The goal of this systematic literature review was to assess the evidence for cost-effectiveness of various surgical techniques in lumbar spinal fusion in conformity with the guidelines provided by the Cochrane Back Review Group. As new technology continuously emerges and divergent directions in clinical practice are present, economic evaluation is needed in order to facilitate the decision-makers' budget allocations. NHS Economic Evaluation Database, MEDLINE, EMBASE and Cochrane Library were searched. Two independent reviewers (one clinical content expert and one economic content expert) applied the eligibility criteria. A list of criteria for methodological quality assessment was established by merging the criteria recommended by leading health economists with the criteria recommended by the Cochrane Back Review Group. The two reviewers independently scored the selected literature and the disagreement was resolved by means of consensus following discussion. Key data were extracted and the level of evidence concluded. Seven studies were eligible; these studies reflected the diversified choices of economic methodology, study populations (diagnosis), outcome measures and comparators. At the conclusion of quality assessment, the methodological quality of three studies was judged credible. Two studies investigated posteolateral fusion (PLF) ± instrumentation in different populations: one investigated non-specific low back pain and one investigated degenerative stenosis + spondylolisthesis. Both studies reflected that cost-effectiveness of instrumentation in PLF is not convincing. The third study concerned the question of circumferential vs anterior lumbar interbody fusion and found a non-significant difference between the techniques. In conclusion, the literature is limited and, in view of the fact that the clinical effects are statistically synonymous, it does not support the use of high-cost techniques. There is a great potential for improvement of methodological quality in economic evaluations of lumbar spinal fusion and further research is imperative.
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In comparison to non-invasive treatments, at least two RCTs demonstrate the evidence of improved clinical outcome [15, 29] whereas two recent trials question the superiority of surgery over time [4, 9] . On the background of the evidence favoring surgery, Fischgrund et al. [13] investigated the effect of transpedicular instrumentation as a support for posteolateral fusion (PLF) in patients suffering from degenerative spondylolisthesis and spinal stenosis. The addition of instrumentation produced no reduction in pain. These findings were replicated by Moller et al. [30] who investigated the effect of instrumentation in isthmic spondylolisthesis (any grade). The first long-term study, published by Christensen et al. [6] concluded bidirectional findings; in isthmic spondylolisthesis (grades 1 and 2). the outcome in non-instrumented cases was superior to those in which the instrumentation was used and in primary degeneration, the reverse situation was found. Other studies have investigated the surgical technique for instrumented lumbar spinal fusion by different choices of intervention and control groups [5, 16, 20, 37] . None of these studies were able to conclude a significant difference between the different approaches to spinal fusion. Thus, the extent to which these approaches differ in terms of cost-effectiveness is highly interesting.
The literature of economic evaluations in chronic low back pain continues to grow as interdisciplinary barriers and methodological weaknesses are overcome [18, 20, 22-24, 27, 34, 37] . On the other hand, the quality of much of the literature on economic evaluations has been criticized as being inferior [17, 19] and moreover, the literature is characterized by broad methodological differences, making it difficult for decision-makers to navigate in the search of value for money. The objective of the present study was to conduct a systematic literature review to assess evidence for the cost-effectiveness of various surgical techniques in lumbar spinal fusion.
Methods
A systematic literature review was conducted in conformity with the method guidelines provided by the Back Review Group in the framework of the Cochrane Collaboration [42, 43] . The review team for the present investigation consisted of two reviewers, each with backgrounds in methodology; one reviewer is a clinical content expert (FBC) and one reviewer an economic content expert (RS). Any disagreement was solved by consensus following discussion. 
Selection of papers
One reviewer performed the electronic literature searches (RS). Two reviewers (RS and FBC) independently examined the titles and abstracts in relation to the criteria for eligibility; if title and abstract did not provide the information necessary for determining eligibility, the complete text was acquired for perusal. After a series of discussions of the inclusion criteria, agreement between reviewers was 100%.
Data extraction
Author, publication year, country, number of participants, diagnosis, interventions, hospital costs of interventions, economic evaluation classification, study design, length of follow-up, effect parameter or instrument, rating of clinical outcome, rating of economic outcome and the author's overall conclusions about ratio of cost-consequence were extracted. All costs were converted into 1999 fiscal year by annual rate of 5% and into EUR by the Purchasing Power Parity Index of the Organization for Economic Co-operation and Development (OECD) [31] .
Methodological quality assessment
Two reviewers independently applied a list of criteria for quality assessment. This list was developed by merging an instrument focused on economic evaluations by Drummond et al. [8] with an instrument focused on clinical trials and used by the Cochrane Back Review Group [42] . The merged list was subsequently reduced according to priority of practicality. The list of criteria is shown in Table 1 . Each criterion was answered simply by ''positive'', ''negative'' or ''ambiguous'' and the horizontal sum of ''positives'' was considered to reflect the overall methodological quality of a study. Further, vertical criteria sums of ''negatives'' were considered to reflect the general problems in the literature.
Data analysis
Due to methodological differences-and especially the diversity of effect measures and intervention groups-no quantitative analysis was possible. Following quality assessment and data extraction, conclusions were drawn within each specific surgical approach encompassed by the present work and the five levels of evidence suggested by the Cochrane Back Review Group were applied [42] .
Results

Literature search
The literature searches revealed a total of 130 references: 20 references indexed by NHS EED, 52 by PubMed, 45 by EMBASE and 13 by the Cochrane Library. Seven references were found eligible for review [14, 20, 22-24, 34, 37] . Except for the article by Hacker and that by Ray, all the articles are joint publications but henceforth will be referred to by the first author only.
Description of included studies Table 2 presents an overview of the literature by means of data extraction from the included studies. The studies included were published from 1997 to 2004 and-except for one Swedish study-they have all been conducted in the USA. One study was a modeling study built on data extractions from original literature, while the others comprised sample sizes ranging from 46 through 294 patients. In total, the literature comprises 676 patients plus the implicit inclusions summarized in the modeling study. The studies represent diversified patient populations: Fritzell and Hacker defined the patient population by chronic, non-specific low back pain, Klara and Ray defined their populations by degenerative disc diseases, the studies by Katz and Kuntz were targeted within degenerative stenosis and finally, Scho¨fferman reported a mixed population of spondylolisthesis, disc degeneration, stenosis and scoliosis.
Three studies investigated the cost-effectiveness of instrumentation in PLF (non-instrumented PLF compared to instrumented PLF) and found incremental costs of the instrumentation to lie between 4,298 and 5,537 EUR. Incremental costs of anterior support in PLF were found to amount to 2,383 EUR in one study. Two studies contrasted circumferential fusion against PLIF and found incremental costs of the circumferential technique between 10,789 and 14,886 EUR. The surgical technique of PLIF alone, however, is not very common today and these incremental costs were measured approximately 10 years ago. Finally, one study investigated the potential cost-effectiveness by approaching 360°without the PLF (270°fusion) and found a cost reduction of 2,795 EUR.
With the exception of one study, all studies were conducted as cost-effectiveness analyses. One study (Kuntz) was a cost-utility analysis and conducted as a modeling study building on data from 15 original papers. In all but the modeling study, the epidemiological designs adapted were longitudinal cohort studies. Fritzell performed a random allocation and Scho¨ffer-man a quasi-random allocation whereas the others were observational studies. Except for the Ray study, all studies had at least 2 years of follow-up.
In relation to the measurement of effects, the literature is truly diversified. Hacker and Ray base their effect measurement solely on such physical facts as operating time and blood loss. No validated instrument, targeted functional ability or pain, was applied to measure the outcome. The other studies implemented such validated instruments as, e.g., the Oswestry Disability Index [11] and the Prolo Scale [33] .
Very few studies were capable of detecting significant differences in effects among interventions. With respect to hospital costs, four studies concluded significant differences among techniques, with the least invasive technique being the least costly and the most invasive technique being the most costly. An explicit synthesis of incremental cost-effectiveness was reported in only two studies: Fritzell reported that the additional costs of an additional effect unit (Oswestry Disability Index) amounts to approximately 1,000 EUR when treating the patients surgically (vs conservative treatment) whereas Kuntz reported that the cost-utility ratio for instrumented PLF (vs non-instrumented PLF) amounts to approximately 2 million EUR per quality-adjusted-lifeyear.
Quality assessment of included studies
The reviewers independently applied the criteria for quality assessment. The list of criteria is presented in Table 1 and the scorings are presented in Table 3 . Overall, the quality of only three studies was found to be methodologically credible; the remainder of the studies did not fulfill more than 50% of the applied criteria. The agreement between the reviewers was good since only Were the eligibility criteria specified? 2b
Was a method of randomization used to allocate the patients? Intervention b 3a
Were index and control interventions explicitly described? 3b
Was the compliance acceptable in all groups? Outcome measurement-costs a 4a
Were all the important and relevant costs and consequences identified? 4b
Were costs and consequences measured accurately in appropriate physical units? 4c
Were costs and consequences valued credibly? Outcome measurement-effect b 5a
Was the outcome assessor blinded to the intervention? 5b
Were the outcome measures relevant? 5c
Was the withdrawal/dropout rate described and acceptable? Economic methodology a 6a
Were costs and consequences adjusted for differential timing? 6b
Was an incremental analysis of costs and consequences of alternatives performed? 6c
Was allowance made for uncertainty in the estimates of costs and consequences? 6d
Did the presentation and discussion of the study results include all issues of concern to users? Statistics
Was the sample size for each group described and discussed in relation to power considerations (if not calculations)? 7b
Did the analysis include the intention-to-treat analysis? 7c
Were the synthesis of costs and benefits reported and if so, were measures of variability presented accordingly for the primary outcome measures? a Adopted from Drummond [8] b
Adopted from van Tulder et al. [42, 43] c 7a and 7c are own modifications Costing by means of group estimates should contain implicit analysis of sensitivity with respect to the findings' sensitivity to under-or overestimation of both central activity measurements and valuations. The criteria of allowance for uncertainty and the criteria of discussing relevant issues of concern to the users should be fulfilled by completion and discussion of an analysis of sensitivity; only Fritzell and Kuntz carried this out. The combination of ''no significant difference'' and ''no explicit power considerations'' provides very little information-especially since economic evaluations comprise at least four stochastic estimates (respectively, costs and effects in both intervention-and control-group) of which the costs have been found to reflect greater variation than effects [26, 45] . This problem is severe in as many as five of seven studies. Finally, only Fritzell and Kuntz reported the explicit synthesis between costs and effects, which should be the paramount analysis in a cost-effectiveness evaluation.
Discussion
The present systematic review was aimed at identifying the evidence concerning the cost-effectiveness of lumbar spinal fusion. Ultimately, we found that the volume of references with credible methodological quality to be extremely limited. There is no other systematic review in the literature that has reviewed this field, which is otherwise a highly emergent aspect of health-services management. Economic evaluations require, in addition to awareness of possible bias from underlying clinical trials, the important considerations in terms of perspective for analysis, the method for costing, incremental analysis and reporting of uncertainty surrounding the incremental cost-effectiveness ratio (ICER). Problems in these areas were widely apparent in the reviewed literature.
From an economic theoretical point of view, the relevant perspective for economic evaluation in spinal fusion is a societal perspective: the costs of production loss from absenteeism and disability constitute an economic impact which greatly exceeds those of the diagnostic, therapeutic and treatment regimens [26, 28] . It is also evident that the cost-effectiveness of an in-hospital treatment cannot be determined without considering the extra-hospital service utilization, as demonstrated in a recent study of service utilization after lumbar spinal fusion and in-hospital rehabilitation [38] . However, when budgets are already earmarked for spinal fusion and the goal is to maximize the gain of health effects within an allocated budget, an administrator's (hospital management's) perspective is justified. Because only two studies in the reviewed literature performed an analysis from the full-scale, societal perspective, we chose to limit data extractions and quality assessment to an administrator perspective.
The method of costing may have crucial impact on conclusions. The methods identified in the present review were in general the average costs or prices (charged third-party payers) obtained from the accounting department of the hospital. Such estimates are rarely specific to spinal fusion or even orthopedics or spine surgery. This may cause a bias that leads to differentiated under-or overestimations of the costs, which in terms of the incremental cost's estimate becomes difficult to interpret (but nevertheless have direct effect on the Ideally, costing should be activity-based while remaining in balance with analysis perspective (for example, a few extra minutes of surgery is insignificant in a broad societal perspective). Overall, and in addition to the specific method for costing, it would be desirable if common guidelines, i.e., the Dutch manual for costing, were adopted in terms of measuring and valuating in a transparent manner [32] . Whether or not the clinical practice is evidence-based, an economic evaluation should compare the new intervention to the best clinical alternative (clinical practice). In other words, the right approach for an economic evaluation is an incremental approach most often concerned about the cost-effectiveness of a new and more sophisticated (costly) intervention. This is not recognized by a great majority of the literature (compares average cost-effectiveness instead of incremental), which relegates the studies to be descriptive rather than decision-analytically. One might argue that the incremental approach is immediately suitable in trial settings with random allocation of patients, but newer methodology describes inherent possibilities in trials with imperfect or missing random allocation of patients as well [21] . Another recurring fact in the reviewed literature is the different choices of comparators. Obviously, a consensus about relevant comparators is lacking and the choice may differ among countries, centers and even surgeons or trialists. Such different choices of comparators (in addition to different populations and outcome measures) hindered the mutual replication. This, of course, has a direct influence on the economic evaluation as it, by virtue of its nature, cannot go beyond the underlying clinical trials. A future possibility for overcoming the challenge of comparability in outcome measurement may be to supplement the outcome evaluation by a generic measure of health-related quality-of-life (HRQoL). However, because different instruments have been found to be non-interchangeable [7] , a certain consensus about the methodology is still required and the question of sensitivity and responsiveness in chronic low back pain needs further investigation as well [2, 40] .
The reporting of an explicit estimate of the synthesis between costs and effects is evidently important and the uncertainty surrounding it should by all means be reported in some way. Although clinical effect differences may verge on being insignificant, economic methodology has ways of quantifying and reporting the uncertainty surrounding the ICER [12, 25] . One common approach is the reporting by means of acceptability curves. Such reporting were seen in only one of the reviewed studies, which is problematical due to the fact that an ICER itself does not follow a rank scale if it is not significantly limited in one quadrant of the costeffectiveness plane [3] . Also, if the clinical difference between the comparators approaches 0, the ICER approaches infinity (as effect differences constitute the denominator in the ICER ratio). Finally, one of the problems with the ratio statistics includes the fact that the ICER is not amendable to regression analysis, which is central in econometrics. These arguments are the foundation for recent trends in health economics, which suggest a transformation of the ICER into a net-benefit measure [21, 39] . It may be that net-benefit (cost-effectiveness) is more significantly influenced by for example, a range of key patient characteristics than by surgical technique itself.
A weakness of the present literature review is the fact that reviewers were not blinded to the authors, institutions and journals throughout the process of selection of literature, quality assessment and extraction of data. The literature is fairly limited and blinding of authors, institutions and journals would not be sufficient, as the few targeted studies conducted all have enjoyed a high impact and visibility throughout the spine research society. Omission of blinding is, however, justified from two studies of methodology, that found such laborintensive process of blinding insignificant to the quality of a review [1, 44] .
Although we adapted a highly sensitive search strategy [36, 42] and extended our search to several databases as suggested by the Cochrane Review Group [42, 43] , this review may be affected by a publication bias. A comprehensive search for abstracts may have decreased the chance of the publication bias, but since economic evaluation in truth is built on clinical studies, the problem of publication bias lies perhaps not within the economic field but rather within the original literature of the clinical effect studies.
Since the conduction of the literature search for the present review, a British randomized trial investigating the cost-utility of lumbar spinal fusion vs conservative treatment has been published [35] . This investigation applies most of the methodological issues discussed above, i.e., they applied the EQ-5D [10] for the measurement of HRQoL. The authors concluded lumbar spinal fusion to be not cost-effective within a 2-year perspective; however, they reasonably underlined the sensitivity of the findings to subsequent surgical treatment in the conservative group, which goes beyond the 2-year follow-up.
Conclusions
On the basis of a systematic literature review of economic evaluations of lumbar spinal fusion, we found that the literature is limited. In other words, the use of heavy-cost techniques is not substantiated by evidence in the literature dealing with cost-effectiveness. In addition to the methodological problems relating to the economic methodology, the reviewed literature was affected by different choices of for example, population and/or outcome measures, which hindered the mutual replication. There is a great potential for improvement of methodological quality in economic evaluations of lumbar spinal fusion and further research is imperative.
